secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2022-12-29T23:59:59+00:00
Accession:  0001185185-22-001458
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director John E. Lynch passes away; Jim Moran appointed to Audit and Compensation Committees
--------------------------------------------------------------------------------

- John E. Lynch, director since Jan 11, 2021, passed away on Dec 24, 2022.
- Former Congressman Jim Moran (director since Jan 18, 2022) appointed to Audit and Compensation Committees effective Dec 27.
- Richard Prins remains Chairman of Board, Audit and Compensation Committees, and Audit financial expert.
- Board continues with three independent directors: Prins, Moran, and one unnamed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518522001458/0001185185-22-001458-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518522001458/indiaglob20221228_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-22-001458

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer